MDxHealth Successfully Completes a EUR 25.0 Million (USD 30.4 Million)(1) Capital Increase
NEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION 21 January 2021, 11:30 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM – 21 January 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage innovative molecular diagnostics company, announces the successful pricing of its capital increase with the offering of new ordinary shares. The […]
MDxHealth Launches Capital Increase and Provides Preliminary 2020 Financial Results
NEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION 21 January 2021, 04:00 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM – 21 January 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage innovative molecular diagnostics company, announces the launch of a capital increase with the offering of new ordinary shares by means […]
MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners
Press release Regulated information. 16 October 2020, 07:00 a.m. CEST IRVINE, CA, and HERSTAL, BELGIUM – 16 October 2020 – M
MDxHealth Provides Q3-2020 Business Update
NEWS RELEASE – REGULATED INFORMATION 21 OCTOBER 2020, 07:00 A.M. CEST IRVINE, CA, and HERSTAL, BELGIUM – October 21, 2020 – M
MDxHealth Provides Q3-2020 Business Update
NEWS RELEASE – REGULATED INFORMATION 21 OCTOBER 2020, 07:00 A.M. CEST IRVINE, CA, and HERSTAL, BELGIUM – October 21, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business update for the third quarter ended September 30, 2020, and the near-term outlook. Michael McGarrity, CEO of MDxHealth, commented: “While […]
MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners
Press release Regulated information 16 October 2020, [07:00] a.m. CEST IRVINE, CA, and HERSTAL, BELGIUM – 16 October 2020 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“) a commercial-stage innovative molecular diagnostics company, announces today that 20,162,924 existing shares have been admitted to listing and trading on the regulated market of Euronext Brussels. The 20,162,924 […]
MDxHealth Reports Half Year 2020 Results
Conference call with Q&A today at 08:00 CET / 07:00 GMT, details provided below IRVINE, CA, and HERSTAL, BELGIUM – August 26
MDxHealth to Report Half Year 2020 Results on Wednesday, August 26, 2020
IRVINE, CA, and HERSTAL, BELGIUM – August 20, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular
MDxHealth Provides Update on Medicare Coverage for SelectMDx
Press Release Regulated Information Inside Information August 7, 2020, 7:00 CET IRVINE, CA and HERSTAL, BELGIUM – August 7,
MDxHealth Announces Results of Special and Extraordinary General Shareholders’ Meetings
Press release Regulated information 30 July 2020, 17:00 CEST IRVINE, CA, and HERSTAL, BELGIUM – 30 July 2020 – MDxHealt
